# Medullary Thyroid Carcinoma

Canonical: https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma/9783031803956

JSON version (same data): https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma/9783031803956.json

![Medullary Thyroid Carcinoma](https://quivercdn.com/covers/springer-nature-switzerland/friedhelm-raue/medullary-thyroid-carcinoma_978-30-3180-395-6-700576eb.webp?v=2026-11-14%2005%3A16%3A30)

- Book: [Medullary Thyroid Carcinoma](https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma) ([Medullary Thyroid Carcinoma.md](https://www.bookquiver.com/friedhelm-raue/medullary-thyroid-carcinoma.md))
- Authors: [Friedhelm Raue](https://www.bookquiver.com/friedhelm-raue), [Karin Frank-Raue](https://www.bookquiver.com/karin-frank-raue)
- Publisher: Springer Nature Switzerland
- ISBN: 978-30-3180-395-6
- Pages: 307
- Published: 2025-03-20
- Language: en_US
- Binding: Hardcover

## Description

Provisional textThis book offers a comprehensive overview of medullary thyroid carcinoma. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. Medullary thyroid carcinoma (MTC) is a rare unique tumor which differs from other thyroid tumors by originating from the neuroendocrine C-cell, secreting the specific tumor marker calcitonin. MTC is associated in about 25% of cases with multiple endocrine neoplasia type 2, an autosomal dominant familial disorder causing tumors within various endocrine glands. The molecular genetics of tumor development is clarified: hereditary as well as sporadic MTC are linked to mutations in the RET proto- oncogene coding for a tyrosine kinase. These RET mutations serve as a genetic marker for hereditary MTC and allow for prophylactic thyroidectomy in gene carriers. The RET-tyrosine kinase is also a new therapeutic target using selective tyrosine kinase inhibitors improving the outcome of advanced metastasized MTC. This book will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.